Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07210671

Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,576 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Superficial venous thrombosis (SVT) is very common in clinical practice. What's more, around 15- 20% of SVTs occur in the context of cancer. Today, cancer patients are excluded from therapeutic trials for DVT. There is therefore no high-level evidence-based treatment recommendation for these patients. Recent data suggest that the course of cancer-associated DVT is similar to that of cancer-associated deep vein thrombosis (DVT). However, there are currently few prospective data on the evolution of cancer-associated DVT in relation to the treatment used. Due to the absence of clear recommendations of treatment in case of SVT associated with cancer the investigators will perform a prospective observational study to evaluate the efficacy of different regiment of anticoagulant treatment ordered in clinical practice.

Conditions

Timeline

Start date
2025-11-10
Primary completion
2027-11-01
Completion
2028-11-01
First posted
2025-10-07
Last updated
2026-04-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07210671. Inclusion in this directory is not an endorsement.

Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous (NCT07210671) · Clinical Trials Directory